GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 362 filers reported holding GLOBUS MED INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $710 | +10.4% | 14,300 | +32.4% | 0.50% | +20.8% |
| Q2 2023 | $643 | +5.1% | 10,800 | 0.0% | 0.41% | +4.5% |
| Q1 2023 | $612 | -40.3% | 10,800 | -21.7% | 0.40% | -44.7% |
| Q4 2022 | $1,025 | -99.9% | 13,800 | 0.0% | 0.72% | +12.8% |
| Q3 2022 | $822,000 | +6.1% | 13,800 | 0.0% | 0.64% | +41.7% |
| Q2 2022 | $775,000 | -99.9% | 13,800 | 0.0% | 0.45% | -2.4% |
| Q1 2022 | $1,018,164,000 | +59164.5% | 13,800 | -42.0% | 0.46% | -37.4% |
| Q4 2021 | $1,718,000 | -5.8% | 23,800 | 0.0% | 0.73% | -4.9% |
| Q3 2021 | $1,824,000 | -1.1% | 23,800 | 0.0% | 0.77% | -3.4% |
| Q2 2021 | $1,845,000 | +25.7% | 23,800 | 0.0% | 0.80% | +23.0% |
| Q1 2021 | $1,468,000 | +19.7% | 23,800 | +26.6% | 0.65% | +18.2% |
| Q4 2020 | $1,226,000 | +56.8% | 18,800 | +19.0% | 0.55% | +43.0% |
| Q3 2020 | $782,000 | +51.8% | 15,800 | +46.3% | 0.38% | +38.6% |
| Q2 2020 | $515,000 | -18.1% | 10,800 | -27.0% | 0.28% | -41.1% |
| Q1 2020 | $629,000 | -43.1% | 14,800 | -21.3% | 0.47% | +5.9% |
| Q4 2019 | $1,106,000 | +15.1% | 18,800 | 0.0% | 0.44% | -1.1% |
| Q3 2019 | $961,000 | – | 18,800 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |